0.332
price up icon3.11%   0.01
pre-market  Pre-mercato:  .33   -0.002   -0.60%
loading

VolitionRX Ltd Borsa (VNRX) Ultime notizie

pulisher
Nov 21, 2025

Freedom Capital Markets lowers VolitionRX stock price target on delayed revenue growth - Investing.com Australia

Nov 21, 2025
pulisher
Nov 21, 2025

Freedom Capital Markets lowers VolitionRX stock price target on delayed revenue growth By Investing.com - Investing.com South Africa

Nov 21, 2025
pulisher
Nov 21, 2025

Can VolitionRX Limited stock sustain breakout momentumEarnings Risk Report & Stepwise Trade Execution Plans - newser.com

Nov 21, 2025
pulisher
Nov 19, 2025

Will VolitionRX Limited stock beat international competitionQuarterly Earnings Summary & Capital Efficient Trading Techniques - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What makes VolitionRx Limited stock attractive to growth fundsJuly 2025 Retail & Accurate Trade Setup Notifications - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Smart tools for monitoring VolitionRx Limited’s price actionWeekly Market Summary & Reliable Breakout Stock Forecasts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How strong is VolitionRx Limited stock balance sheet2025 Major Catalysts & Safe Capital Growth Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How VolitionRX Limited stock trades after rate cutsQuarterly Performance Summary & Expert-Curated Trade Recommendations - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

H.C. Wainwright lowers VolitionRX stock price target on valuation update By Investing.com - Investing.com Nigeria

Nov 18, 2025
pulisher
Nov 18, 2025

Are Smart Investors Making the Right Decision? VolitionRX Ltd (VNRX) - Setenews

Nov 18, 2025
pulisher
Nov 18, 2025

H.C. Wainwright lowers VolitionRX stock price target on valuation update - Investing.com

Nov 18, 2025
pulisher
Nov 18, 2025

VolitionRx price target lowered to $1.50 from $2.50 at H.C. Wainwright - MSN

Nov 18, 2025
pulisher
Nov 17, 2025

Reynolds, Volitionrx CEO, buys $7,000 in VNRX stock By Investing.com - Investing.com Nigeria

Nov 17, 2025
pulisher
Nov 17, 2025

Reynolds, Volitionrx CEO, buys $7,000 in VNRX stock - Investing.com

Nov 17, 2025
pulisher
Nov 17, 2025

CEO Reynolds Buys 20,000 ($7K) Of VolitionRX Ltd [VNRX] - TradingView

Nov 17, 2025
pulisher
Nov 17, 2025

[Form 4] VOLITIONRX LTD Insider Trading Activity - Stock Titan

Nov 17, 2025
pulisher
Nov 17, 2025

VolitionRX (VNRX) Target Price Lowered by HC Wainwright & Co. | - GuruFocus

Nov 17, 2025
pulisher
Nov 17, 2025

VolitionRX (VNRX): Analyst Jason Kolbert Reaffirms Buy Rating wi - GuruFocus

Nov 17, 2025
pulisher
Nov 16, 2025

VolitionRx Limited Reports Q3 2025 Financial Growth - MSN

Nov 16, 2025
pulisher
Nov 16, 2025

VolitionRx Ltd. Earnings Call Highlights Growth and Partnerships - The Globe and Mail

Nov 16, 2025
pulisher
Nov 16, 2025

Using Ichimoku Cloud for VolitionRx Limited technicalsLong Setup & Detailed Earnings Play Alerts - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Is VolitionRX Limited stock resilient in recession scenariosSell Signal & High Return Trade Opportunity Guides - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

VolitionRx Limited (AMEX:VNRX) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 15, 2025
pulisher
Nov 14, 2025

Volitionrx Ltd earnings missed by $0.01, revenue fell short of estimates - Investing.com Nigeria

Nov 14, 2025
pulisher
Nov 14, 2025

Market reaction to VolitionRx Limited’s recent newsTrade Signal Summary & Technical Pattern Based Signals - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

Earnings call transcript: VolitionRx Ltd reports Q3 2025 revenue growth, stock stable - Investing.com Nigeria

Nov 14, 2025
pulisher
Nov 14, 2025

Earnings call transcript: VolitionRx Ltd reports Q3 2025 revenue growth, stock stable By Investing.com - Investing.com South Africa

Nov 14, 2025
pulisher
Nov 14, 2025

[SCHEDULE 13G/A] VOLITIONRX LTD SEC Filing - Stock Titan

Nov 14, 2025
pulisher
Nov 14, 2025

VolitionRX Ltd (VNRX) Q3 2025 Earnings Call Highlights: Strategic Partnerships and Revenue ... By GuruFocus - Investing.com Canada

Nov 14, 2025
pulisher
Nov 14, 2025

VolitionRX Ltd (VNRX) Q3 2025 Earnings Call Highlights: Strategi - GuruFocus

Nov 14, 2025
pulisher
Nov 14, 2025

VolitionRX Ltd (VNRX) Q3 2025 Earnings Call Highlights: Strategic Partnerships and Revenue ... - Yahoo Finance

Nov 14, 2025
pulisher
Nov 14, 2025

VolitionRX Q3 2025 Earnings Call Transcript - MarketBeat

Nov 14, 2025
pulisher
Nov 14, 2025

VolitionRX: Q3 Earnings Snapshot - CTPost

Nov 14, 2025
pulisher
Nov 14, 2025

Volitionrx Ltd earnings missed by $0.01, revenue fell short of estimates By Investing.com - Investing.com Canada

Nov 14, 2025
pulisher
Nov 13, 2025

VNRX Advances with Strategic Partnerships and Licensing Deals - GuruFocus

Nov 13, 2025
pulisher
Nov 13, 2025

[8-K] VOLITIONRX LTD Reports Material Event | VNRX SEC FilingForm 8-K - Stock Titan

Nov 13, 2025
pulisher
Nov 13, 2025

VolitionRx (NYSE American: VNRX) posts Q3 revenue $0.6M; cash used in ops $3.6M - Stock Titan

Nov 13, 2025
pulisher
Nov 13, 2025

Regression analysis insights on VolitionRx Limited performanceMarket Growth Review & Risk Controlled Swing Alerts - newser.com

Nov 13, 2025
pulisher
Nov 13, 2025

VolitionRX Ltd (VNRX) Q3 2025: Everything You Need to Know Ahead of Earnings - GuruFocus

Nov 13, 2025
pulisher
Nov 13, 2025

VolitionRx Limited Announces Third Quarter 2025 Financial Results and Business Update - Yahoo Finance

Nov 13, 2025
pulisher
Nov 12, 2025

A Preview Of VolitionRX's Earnings - Benzinga

Nov 12, 2025
pulisher
Nov 11, 2025

VolitionRx (NYSE:VNRX) Trading Up 0.6% – Here’s Why - Defense World

Nov 11, 2025
pulisher
Nov 10, 2025

[8-K/A] VOLITIONRX LTD Amends Material Event Report | VNRX SEC FilingForm 8-K/A - Stock Titan

Nov 10, 2025
pulisher
Nov 10, 2025

Perhaps timely catching VolitionRX Ltd (VNRX) would be a good idea - Setenews

Nov 10, 2025
diagnostics_research DGX
$190.58
price down icon 0.35%
diagnostics_research LH
$265.31
price down icon 0.12%
diagnostics_research WAT
$399.54
price up icon 1.41%
diagnostics_research MTD
$1,470.14
price up icon 1.22%
$238.58
price up icon 3.45%
diagnostics_research IQV
$228.18
price up icon 1.46%
Capitalizzazione:     |  Volume (24 ore):